KR20050103185A - 출혈과 관련된 신경계 손상의 치료 방법 - Google Patents

출혈과 관련된 신경계 손상의 치료 방법 Download PDF

Info

Publication number
KR20050103185A
KR20050103185A KR1020057008192A KR20057008192A KR20050103185A KR 20050103185 A KR20050103185 A KR 20050103185A KR 1020057008192 A KR1020057008192 A KR 1020057008192A KR 20057008192 A KR20057008192 A KR 20057008192A KR 20050103185 A KR20050103185 A KR 20050103185A
Authority
KR
South Korea
Prior art keywords
tudca
bleeding
patient
bcl
ursodeoxycholic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020057008192A
Other languages
English (en)
Korean (ko)
Inventor
클리포드 제이. 스틸러
왈터 씨. 로우
세실리아 엠. 피. 로드리게스
전홍 난
Original Assignee
리전츠 오브 더 유니버스티 오브 미네소타
클리포드 제이. 스틸러
왈터 씨. 로우
세실리아 엠. 피. 로드리게스
전홍 난
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 리전츠 오브 더 유니버스티 오브 미네소타, 클리포드 제이. 스틸러, 왈터 씨. 로우, 세실리아 엠. 피. 로드리게스, 전홍 난 filed Critical 리전츠 오브 더 유니버스티 오브 미네소타
Publication of KR20050103185A publication Critical patent/KR20050103185A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
KR1020057008192A 2002-11-07 2003-10-08 출혈과 관련된 신경계 손상의 치료 방법 Withdrawn KR20050103185A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US42521002P 2002-11-07 2002-11-07
US60/425,210 2002-11-07
US45161503P 2003-03-03 2003-03-03
US60/451,615 2003-03-03

Publications (1)

Publication Number Publication Date
KR20050103185A true KR20050103185A (ko) 2005-10-27

Family

ID=32314576

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020057008192A Withdrawn KR20050103185A (ko) 2002-11-07 2003-10-08 출혈과 관련된 신경계 손상의 치료 방법

Country Status (8)

Country Link
US (1) US20060135494A1 (cg-RX-API-DMAC7.html)
EP (1) EP1575578B1 (cg-RX-API-DMAC7.html)
JP (1) JP2006510740A (cg-RX-API-DMAC7.html)
KR (1) KR20050103185A (cg-RX-API-DMAC7.html)
AT (1) ATE451108T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003275495A1 (cg-RX-API-DMAC7.html)
DE (1) DE60330501D1 (cg-RX-API-DMAC7.html)
WO (1) WO2004043342A2 (cg-RX-API-DMAC7.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018048274A1 (ko) * 2016-09-12 2018-03-15 경상대학교 산학협력단 간손상 예방, 개선 또는 치료용 조성물
KR20190009174A (ko) * 2017-07-18 2019-01-28 의료법인 성광의료재단 우르소데옥시콜산을 함유하는 염증성 질환 또는 척수 손상 예방 또는 치료용 조성물

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7772220B2 (en) 2004-10-15 2010-08-10 Seo Hong Yoo Methods and compositions for reducing toxicity of a pharmaceutical compound
US20030044413A1 (en) * 2000-08-15 2003-03-06 Regents Of The University Of Minnesota Methods of limiting apoptosis of cells
US20060204481A1 (en) * 2003-04-02 2006-09-14 Steer Clifford J Methods of promoting cell viability
ES2339790T3 (es) * 2004-08-30 2010-05-25 Seo Hong Yoo Efecto neuroprotector de udca solubilizado en modelo isquemico focal.
DE602005027727D1 (de) 2004-10-15 2011-06-09 Seo Hong Yoo Zusammensetzungen zur verringerung der toxizität von cisplatin, carboplatin und oxaliplatin
JP2008530100A (ja) * 2005-02-10 2008-08-07 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ 視覚障害の治療方法
AU2007230989A1 (en) * 2006-03-22 2007-10-04 President And Fellows Of Harvard College Methods and compositions for treating hypercholesterolemia and atherosclerosis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2138971T3 (es) * 1991-07-03 2000-02-01 Otsuka Pharma Co Ltd Regulador de la apoptosis.
US5656725A (en) * 1995-05-12 1997-08-12 Apoptosis Technology, Inc. Peptides and compositions which modulate apoptosis
WO1999015179A1 (en) * 1997-09-25 1999-04-01 Regents Of The University Of Minnesota Methods of limiting apoptosis of cells
WO1999043336A1 (en) * 1998-02-27 1999-09-02 Nutramax Laboratories, Inc. L-ergothioneine, milk thistle, and s-adenosylmethionine for the prevention, treatment and repair of liver damage
GB0019290D0 (en) * 2000-08-04 2000-09-27 Symphar Sa Methods for inducing apolipoprotein E secretion
US20030044413A1 (en) * 2000-08-15 2003-03-06 Regents Of The University Of Minnesota Methods of limiting apoptosis of cells

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018048274A1 (ko) * 2016-09-12 2018-03-15 경상대학교 산학협력단 간손상 예방, 개선 또는 치료용 조성물
KR20190009174A (ko) * 2017-07-18 2019-01-28 의료법인 성광의료재단 우르소데옥시콜산을 함유하는 염증성 질환 또는 척수 손상 예방 또는 치료용 조성물

Also Published As

Publication number Publication date
HK1086479A1 (zh) 2006-09-22
EP1575578A2 (en) 2005-09-21
DE60330501D1 (de) 2010-01-21
WO2004043342A3 (en) 2004-07-15
JP2006510740A (ja) 2006-03-30
AU2003275495A8 (en) 2004-06-03
EP1575578A4 (en) 2007-10-10
EP1575578B1 (en) 2009-12-09
ATE451108T1 (de) 2009-12-15
WO2004043342A2 (en) 2004-05-27
AU2003275495A1 (en) 2004-06-03
US20060135494A1 (en) 2006-06-22

Similar Documents

Publication Publication Date Title
KR102459500B1 (ko) 퀘르세틴 배당체를 함유하는 근위축 억제제
Wakade et al. Curcumin attenuates vascular inflammation and cerebral vasospasm after subarachnoid hemorrhage in mice
Nair et al. Grape seed extract proanthocyanidins downregulate HIV-1 entry coreceptors, CCR2b, CCR3 and CCR5 gene expression by normal peripheral blood mononuclear cells
Shimada et al. Polaprezinc down-regulates proinflammatory cytokine-induced nuclear factor-κB activiation and interleukin-8 expression in gastric epithelial cells
WO2001000215A1 (en) Compositions for treating or preventing neurodegeneration and cognitive decline
KR20020035855A (ko) 약용인삼을 포함하는 뇌세포 또는 신경세포 보호제
JP2019537628A (ja) 併用療法
JP7737548B2 (ja) 抗炎症活性を有するペプチドとその用途
Xie et al. Ginsenoside Rb1, a panoxadiol saponin against oxidative damage and renal interstitial fibrosis in rats with unilateral ureteral obstruction
KR20220014187A (ko) 위릉채 추출물 또는 쪽 추출물을 함유하는 근위축 개선, 예방 또는 치료용 조성물
Chakrabarti et al. MiR-7-1 potentiated estrogen receptor agonists for functional neuroprotection in VSC4. 1 motoneurons
CN111867610B (zh) 用于预防或治疗呼吸系统疾病的生药组合物
EP1575578B1 (en) Methods of treating injuries of the nervous system associated with hemorrhage
JP4213617B2 (ja) カルシトニン遺伝子関連ペプチド産生及び放出促進作用を有する、胃粘膜傷害予防・治療用可食性組成物および育毛用可食性組成物
Cao et al. Vitamin E inhibits activated chaperone-mediated autophagy in rats with status epilepticus
KR101953298B1 (ko) 우르소데옥시콜산을 함유하는 염증성 질환 또는 척수 손상 예방 또는 치료용 조성물
CA2541548A1 (en) Treatment of diseases involving erbb2 kinase overexpression
KR101673988B1 (ko) 피부암의 치료 또는 전이 억제용 조성물
KR102534210B1 (ko) 노봉방 추출물을 유효성분으로 포함하는 비만의 예방 또는 치료용 약학적 조성물
JP2025143432A (ja) 尿路機能改善用組成物及び膀胱血流改善用組成物
KR20010078734A (ko) 허혈로부터 뉴론의 보호방법
CN100421656C (zh) 乌索脱氧胆酸在制备治疗与出血相关的神经系统损伤的药物中的用途
KR102479869B1 (ko) 당단풍나무 추출물 또는 이의 분획물을 포함하는 전립선암 예방, 치료, 또는 개선용 조성물
JP2021508735A (ja) ゴカヒ、ロコン、及びアカマツ抽出物を有効成分として含む前立腺疾患の予防、治療、又は改善用組成物
KR102454513B1 (ko) 황해쑥(Artemisia argyl, 품종:섬애) 추출물을 유효성분으로 포함하는 관절염 예방 또는 치료용 조성물

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20050507

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
N231 Notification of change of applicant
PN2301 Change of applicant

Patent event date: 20051123

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid